Effects of the partial glycine agonist D-cycloserine on cognitive functioning in chronic low dose MPTP-treated monkeys

Brain Research

Volumn 860, Issue 1-2, 2000, Pages 190-194

  Schneider, J S ^a   Tinker, John P ^a   Van Velson, Maria ^a   Giardiniere, Michele ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cognition; Glycine; Monkey; MPTP; NMDA

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CYCLOSERINE; DIZOCILPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; MALE; MEMORY; MONKEY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RECOGNITION; TASK PERFORMANCE; VISUAL DISCRIMINATION; VISUAL MEMORY;

ANIMALS; COGNITION; CYCLOSERINE; DISCRIMINATION (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; MACACA FASCICULARIS; MALE; MPTP POISONING; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE, SECONDARY; PSYCHOMOTOR PERFORMANCE; REACTION TIME; VISUAL PERCEPTION;

EID: 0034737761     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02036-9     Document Type: Article

References (29)

1. T.G. Aigner, Pharmacology of memory: cholinergic-glutamatergic interactions, Curr. Opin. Neurobiol. 5 (1995) 155-160.
2. R.L. Albin, A.B. Young, J.B. Penny, The functional anatomy of basal ganglia disorders, Trends Neurosci. 12 (1989) 366-375.
3. C. Bischoff, P.I. Tiedtke, Competitive and non-competitive NMDA receptor antagonists in spatial learning tasks, Eur. J. Pharmacol. 213 (1992)269-273.
4. J.M. Brotchie, I.J. Mitchell, M.A. Sambrook, A.R. Crossman, Alleviation of Parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate, Mov. Disord. 6 (1991) 133-138.
5. G.L. Collingridge, T.V.P. Bliss, NMDA receptors - their role in long-term potentiation, Trends Neurosci. 10 (1987) 288-293.
6. A.R. Crosssman, D. Peggs, S. Boyce, M.R. Luquin, M.A. Sambrook, Effect of the NMDA atagonist MK-801 on MPTP-induced Parkinsonism in the monkey, Neuropharmacology 11 (1989) 1271-1273.
7. I. Divac, H.E. Rosvold, M.K. Szarcbart, Behavioral effects of selective ablation of the caudate nucleus, J. Comp. Physiol. Psychol. 63 (1967) 184-190.
8. E.F. Domino, J. Sheng, N-methyl-D-aspartate receptor antagonist and dopamine Dl and D2 agonist interactions in l-methyl-4-phenyl1,2,5,6-tetrahydropyridine-induced hemiParkinsonian monkeys, J. Pharmacol. Exp. Ther. 264 (1993) 221-225.
9. R.J. Fishkin, E.S. Ince, W.A. Carlezon Jr., R.W. Dunn, D-Cylcoserine attenuates scopolamine-induced learning and memory deficits in rats, Behav. Neural Biol. 59 (1993) 150-157.
10. J.T. Greenamyre, R.V. Eller, Z. Zhang, A. Ovadia, R. Kurlan, D.M. Gash, AntiParkinson effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease, Ann. Neurol. 35 (1994) 655-661.
11. T. Klockgether, L. Turski, NMDA antagonists potentiate antiParkinsonian actions of L-DOPA in monoamine-depleted rats, Ann. Neurol. 28 (1990) 539-546.
12. T. Klockgether, L. Turski, T. Honore, Z.M. Zhang, D.M. Gash, R. Kurlan, J.T. Greenamyre, The AMPA receptor antagonist NBQX has antiParkinsonian effects in monoamine depleted rats and MPTP treated monkeys, Ann. Neurol. 30 (1991) 717-723.
13. T.H. Lanthorn, D-Cycloserine: agonist turned antagonist, Amino Acids 6(1994)247-260.
14. N. Matsuoka, T.G. Aigner, D-Cylsoserine, a partial agonist at the glycine site coupled to A'-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys, J. Pharmacol. Exp. Ther. 278 (1996) 189-197.
15. N. Matsuoka, T.G. Aigner, The glycine/NMDA receptor antagonist HA-966 impairs visual recognition memory in rhesus monkeys, Brain Res. 731 (1996) 72-78.
16. N. Matsuoka, T.G. Aigner, Cholinergic-glutamatergic interactions in visual recognition memory of rhesus monkeys, NeuroReport 7 (1996)565-568.
17. L.M. Nishimura, R.J. Boegman, N-methyl-D-aspartate-evoked release of acetylcholine form the medial septum/diagonal band of rat brain, Neurosci. Lett. 115 (1990) 259-264.
18. H. Ogura, T.G. Aigner, MK-801 impairs recognition memory in rhesus monkeys: comparison with cholinergic drugs, J. Pharmacol. Exp. Ther. 266 (1993) 60-64.
19. M. Ohno, T. Yamamoto, S. Watanabe, Intrahippocampal administration of a glycine site antagonist impairs working memory performance of rats, Eur. J. Pharmacol. 253 (1994) 183-187.
20. 3H]dopamine from rat striatal slices, Neurosci. Lett. 96 (1989) 323-328.
21. N.M.J. Rupniak, S. Boyce, M.J. Steventon, S.D. Iversen, C.D. Marsden, Dystonia induced by combined treatment with L-DOPA and MK-801 in Parkinsonian monkeys, Ann. Neurol. 32 (1992) 103-105.
22. N.M.J. Rupniak, M. Duchnowski, S.J. Tye, G. Cook, S.D. Iversen, Failure of D-cycloserine to reverse cognitive disruption induced by scopolamine or phencyclidine in primates, Life Sci. 50 (1992) 1959-1962.
23. W.J. Schmidt, M. Bubser, Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats, Pharmacol. Biochem. Behav. 32 (1989) 621-623.
24. J.S. Schneider, Chronic exposure to low doses of MPTP: II. Neurochemical and pathological consequences in cognitively-impaired, motor asymptomatic monkeys, Brain Res. 534 (1990) 25-36.
25. J.S. Schneider, C.J. Kovelowski, Chronic exposure to low doses of MPTP: I. Cognitive deficits in motor asymptomatic monkeys, Brain Res. 519 (1990) 122-128.
26. J.S. Schneider, D.P. Roeltgen, Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low dose MPTP-treated monkeys, Brain Res. 615 (1993) 351-354.
27. J.S. Schneider, J.P. Tinker, M. Van Velson, F. Menzaghi, G.K. Lloyd, Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low dose MPTP-treated monkeys, J. Pharmacol. Exp. Ther. 290 (1999) 731-739.
28. J.S. Schneider, M. Van Velson, F. Menzaghi, G.K. Lloyd, Treatment with the nicotinic acetylcholine receptor agonist SIB-1508Y improves object retrieval performance in MPTP-treated monkeys: comparison with levodopa treatment, Ann. Neurol. 43 (1998) 311-317.
29. G.B. Watson, M.A. Bolanowski, M.P. Baganoff, C.L. Deppeler, T.H. Lanthorn, D-Cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed Xenopus oocytes, Brain Res. 510(1990) 158-160.